All industriesHealthcare & Life Sciences

Lead Generation for Pharmaceuticals & Biotech

Pharma & biotech lead generation for service and tech vendors. SalesHive books meetings with clinical, regulatory, manufacturing, and commercial leaders.

Book a 30-minute callCompare plans

Monthly or annual plans. You approve the strategy before launch.

Your market / Pharmaceuticals & Biotech
Buyers and starting point

Who we reach in Pharmaceuticals & Biotech

Your market. Your outreach plan.

Start with the roles that own the problem your offer solves. Agree on the accounts, buying team and channels before launch.
Who we reach

We Target Your Ideal Pharmaceuticals & Biotech Buyers

Who owns the budget depends on what you sell, so we match the first contact to your offer. Our SDRs then engage life sciences stakeholders with precise, technical messaging tailored to therapeutic area, modality, and where the organization sits in the development-to-commercialization lifecycle.

Build my target list
Buyer coverageTypical owners, by what you sell
  • 01VP / Head of Clinical Operations (trial services and eClinical tools)
  • 02Director of Regulatory Affairs (submission and regulatory support)
  • 03VP, Technical Operations, Manufacturing / MSAT (CDMO, analytical, and manufacturing services)
  • 04Head of Market Access & Payer Strategy (pricing, HEOR, and access consulting)
  • 05Director of Commercial Operations / Sales Operations (commercial data, CRM, and field tools)
Cold calling
Managed outreach
Email outreach
Campaign support
Targeted lists
Account research
US + Philippines
SDR team options
See the industry record
Our Pharmaceuticals & Biotech track record

Yes, we have run Pharmaceuticals & Biotech outbound before.

These figures come straight from our CRM: every client account tagged with a Pharmaceuticals & Biotech industry that we booked meetings for. Client names stay private. Ask on your strategy call how those campaigns were targeted and what worked.

6Pharmaceuticals & Biotech client accounts
112Meetings booked for them
2019First year on record

Counted from client industry tags: biotechnology, pharmaceuticals. Minimum figures; refreshed hourly. Recorded meeting bookings, not attendance or closed revenue.

Who we reach

We Target Your Ideal Pharmaceuticals & Biotech Buyers

Who owns the budget depends on what you sell, so we match the first contact to your offer. Our SDRs then engage life sciences stakeholders with precise, technical messaging tailored to therapeutic area, modality, and where the organization sits in the development-to-commercialization lifecycle.

Build my target list
Buyer coverageTypical owners, by what you sell
  • 01VP / Head of Clinical Operations (trial services and eClinical tools)
  • 02Director of Regulatory Affairs (submission and regulatory support)
  • 03VP, Technical Operations, Manufacturing / MSAT (CDMO, analytical, and manufacturing services)
  • 04Head of Market Access & Payer Strategy (pricing, HEOR, and access consulting)
  • 05Director of Commercial Operations / Sales Operations (commercial data, CRM, and field tools)
Industry brief

Built for how Pharmaceuticals & Biotech buyers actually buy

SalesHive is a B2B lead generation agency that books qualified meetings for companies selling services and technology to pharmaceutical and biotech organizations, such as CROs, CDMOs, software vendors, and consultancies, with buyers across R and D, clinical, regulatory, manufacturing, and commercial teams. This page covers B2B selling to those teams, not promoting medicines to prescribers or patients.

SDR teams run outbound across targeted lists, personalized email, and cold calling, positioning offers for Clinical Operations, Regulatory Affairs, Technical Operations, and Market Access leaders who weigh validation and risk as heavily as features.

You approve every message before launch, and your legal or compliance reviewers decide which claims are allowed. Sequences also account for long evaluation cycles, where momentum stalls as priorities shift from discovery to clinical or from launch to lifecycle management.

Worked example (invented for illustration, not a SalesHive client or result). A vendor sells software that forecasts clinical trial supply for sponsors running multi-site studies.

1. Accounts. Use the public ClinicalTrials.gov registry to find companies sponsoring interventional Phase 2 or Phase 3 studies that are recruiting or not yet recruiting. Leave out preclinical-only companies, which have no trial supply to plan yet, and decide up front whether you can handle the procurement and validation demands of the largest sponsors.

2. Roles. The Head of Clinical Operations or the clinical supply lead owns the problem. Quality reviews validation, IT checks data handling, and procurement or vendor management runs onboarding.

3. Ownership check. Many sponsors outsource parts of a study to a CRO, so ask early who chooses tools for this study. If the CRO decides, the CRO becomes the account to pursue.

4. Meeting objective and qualification. The first call confirms upcoming study starts, how supply is forecast today, and who would join a deeper evaluation. No near-term studies, or a recent multi-year commitment to another tool, usually means a later follow-up instead of a meeting now. Our SDRs book and qualify that first call; your team runs the evaluation and answers quality and validation questions.

Bring your offer and your target accounts. Let’s define the right first conversation.

Book a 30-minute call
The Challenge

Why Pharmaceuticals & Biotech Sales Development is Hard

Between strict review of claims, long vendor qualification, and decisions spread across science, quality, and commercial teams, vendors need precise targeting and disciplined messaging to earn meetings.

01

Compliance-first outreach expectations

Pharma and biotech buyers are trained to spot risk, especially around claims, inducements, and how data is handled. If your messaging feels promotional, unsubstantiated, or unclear on intended use, it can end the conversation before it starts.

02

Slow evaluation and onboarding

Even when there’s urgency, vendor onboarding often requires security reviews, quality oversight, and cross-functional approvals. Sales cycles stretch when prospects need validation plans, SOP alignment, and internal buy-in before a pilot can begin.

03

Many stakeholders, no clear owner

Purchasing decisions span R&D, clinical, QA, IT, procurement, and commercial teams, each with different success metrics. A single champion rarely controls the process, so progress depends on building consensus across the account.

04

Budget volatility and reprioritization

Biotech budgets can change quickly with financing cycles, trial results, partnership news, or internal portfolio decisions. A project that looked funded last month can be paused, re-scoped, or moved to a different team overnight.

05

Heavy documentation requirements

Life sciences buyers often expect proof, not promises, quality documentation, audit readiness, and clear contractual language. If you can’t quickly provide the right artifacts and answers, prospects may choose a “safer” incumbent.

06

Market access and pricing pressure

Commercial and market access teams face ongoing pressure from payers, formulary controls, and pricing scrutiny. The FTC’s July 2024 interim staff report found that the three largest pharmacy benefit managers processed nearly 80% of prescriptions dispensed by U.S. pharmacies in 2023, which raises the bar for ROI on any new commercial initiative. Vendors must connect value directly to outcomes like launch readiness, speed-to-insight, or operational efficiency.

Our Approach

How We Generate Leads for Pharmaceuticals & Biotech

We combine carefully reviewed messaging, precise list building, and persistent multi-threaded outreach to book meetings with the right life sciences stakeholders at the right moment.

01

Carefully reviewed email outreach

We build messaging that respects industry guardrails while still creating urgency, grounded in use cases like clinical operations efficiency, quality readiness, manufacturing continuity, or commercial execution. Sequences are tailored by persona and lifecycle stage (discovery, clinical, tech transfer, launch, post-market).

Explore email outreach
02

Cold calling for access

When inboxes are crowded and gatekeeping is real, calling helps you break into target accounts and identify the true owners of initiatives. Our SDRs use structured call plays to multi-thread across functions and convert interest into scheduled meetings.

Explore cold calling
03

Lifecycle-based list building

We build and QA lists aligned to how pharma and biotech actually buy, by therapeutic area, modality, trial phase, manufacturing footprint, and commercial maturity. That means fewer wasted touches and more conversations with teams that have an active need right now.

Explore list building
04

Personalization at scale

SalesHive’s platform and AI-driven personalization help your outreach feel relevant without slowing down execution. We continuously optimize deliverability, messaging performance, and account coverage so you can forecast pipeline with confidence.

Tour the platform

Thirty minutes with a strategist who has run Pharmaceuticals & Biotech outbound before beats another month of guessing.

Book a strategy call
A clear starting point

The plan comes first. You approve the launch.

  1. 01 / Fit

    Define your market

    Agree on the accounts, buying roles, exclusions and what makes a meeting qualified.

  2. 02 / Review

    Approve the playbook

    Review the targeting, lists and messaging before outreach starts.

  3. 03 / Launch

    Start the conversations

    Most programs launch within a month of kickoff, typically in about three weeks. Timing depends on your approvals.

  4. 04 / Learn

    Review and refine

    Track calls, responses and booked meetings. Refine the plan around what your buyers tell us.

Cost and terms

One monthly package

One custom-quoted monthly fee for your SDR team, strategist, platform and data. No setup fees. Month-to-month and annual plans are available. You owe $0 until you approve launch.

Compare scope and pricing
Quality and fit

Agree on the criteria

Your offer, market and buyer response shape the results. No fixed meeting count is guaranteed. Define qualification before launch and review the conversations, not just the booking total.

See how the process works
Book a 30-minute callCompare plans

Questions, answered

Pharmaceuticals & Biotech outbound, explained

The short version is on the surface. Open any question to go deeper.

Why is lead generation harder when selling to pharmaceutical and biotech companies than in most B2B industries?
Pharma and biotech buyers expect compliance-first, evidence-based messaging, and they quickly disengage from anything that sounds like an unsubstantiated claim or unclear “intended use.” Sales cycles are also slower because decisions span R&D, clinical, quality, IT, procurement, and commercial teams, often requiring security reviews, validation expectations, and documented processes before a pilot even starts. On top of that, priorities can shift fast with trial timelines, portfolio changes, or financing events, which can stall deals mid-stream.
Who should we target in pharma and biotech outbound to consistently book qualified meetings?
The right targets depend on where an organization sits in the development-to-commercialization lifecycle and what outcome you impact (trial execution, quality readiness, manufacturing continuity, launch performance, or market access). We commonly build account maps that include clinical operations, regulatory/quality, technical operations (MSAT/manufacturing), and commercial operations, then multi-thread outreach to find the real initiative owner. A quick way to start is to match your offer to the function that buys it: Clinical Operations buys trial services and eClinical tools, Regulatory Affairs buys submission and regulatory support, Technical Operations and MSAT buy manufacturing and analytical services, Market Access buys pricing, HEOR, and payer strategy work, and Commercial Operations buys commercial data and field tools. Company stage matters too, since a preclinical biotech rarely has market access or commercial teams yet, while a commercial-stage company does. This reduces “dead-end” conversations and increases the odds of booking a meeting that can actually move forward.
How does SalesHive keep email outreach careful and credible for pharma and biotech audiences?
You approve every message before launch, and your own compliance reviewers decide which claims are allowed; we do not make regulatory determinations for you. We help you lead with precise, non-promotional positioning focused on operational outcomes and validated use cases, while avoiding language that can trigger compliance concerns (e.g., exaggerated performance claims or ambiguous data handling). Our team tailors sequences by persona and lifecycle stage, and we use our AI-powered platform with eMod personalization to make messages feel relevant without sacrificing consistency. We also continuously monitor deliverability and reply signals so you can scale outreach while protecting your domain reputation.
Does cold calling still work for pharma and biotech lead generation when gatekeeping is intense?
Yes, calling is often the fastest way to confirm who owns an initiative, understand what “stage” the account is in (clinical, tech transfer, launch, post-market), and route around inbox congestion. We use structured call plays designed for life sciences stakeholders, focusing on permission-based conversations and clear next steps rather than pushy pitching. Cold calling also enables multi-threading across functions to build consensus and convert interest into scheduled meetings.
What should we have ready to reduce friction after a pharma or biotech prospect says “this looks interesting”?
Expect detailed questions about security, data handling, quality processes, validation expectations, and contract language, often before a formal pilot is approved. We help by pre-qualifying accounts during outreach, capturing requirements early, and setting meetings with the right stakeholders so your team isn’t stuck repeating discovery with non-decision makers. Your strategist also adjusts targeting and messaging each week as new objections and documentation requirements surface.
Healthcare & Life Sciences

Adjacent industries we also run

Healthcare IT Healthcare Services Medical Devices Telehealth All 47+ industries

Your next conversation

Build your next buyer conversation.

Choose a 30-minute time and we will map out exactly how SalesHive can book meetings for your team.

Category: Healthcare & Life Sciences